Evidence available on the use of the selective β3-adrenoceptor agonist mirabegron for the treatment of overactive bladder

  1. Angulo, J.C.
  2. Khullar, V.
  3. Nitti, V.W.
  4. Siddiqui, E.
Revue:
Actas Urologicas Espanolas

ISSN: 0210-4806

Année de publication: 2013

Volumen: 37

Número: 10

Pages: 640-651

Type: Brève étude

DOI: 10.1016/J.ACURO.2013.05.003 GOOGLE SCHOLAR
La source de données: Scopus